Transarterial chemoembolization (TACE) improves survival in cirrhotic patients with hepatocellular carcinoma (HCC). The optimal schedule, best anticancer agent and best technique are still unclear.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback